New Research Validates Clinical Value of Treating Copperhead Envenomation with CroFab®

By In The News
March 5, 2019 in The Headlines

Recommended Posts

In The News

Posted March 5, 2019

- Share

Posted March 5, 2019

PHILADELPHIA, March 5, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), the global healthcare company, announced that research published today in PLOS ONE establishes the Patient-Specific Functional Scale (PSFS) as a valid, reliable, and clinically meaningful measure for assessing quality of life ...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  222025
2. Jaydee
  17787
3. deicer
  13345
4. Kip Powick
  12311
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.4k
- Total Posts
  
  565k

Sign In

New Research Validates Clinical Value of Treating Copperhead Envenomation with CroFab®

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support